Amgen Says FDA Approved Prescribing Information Update Cutting IMDELLTRA Monitoring Time For First Two Doses To 6 To 8 Hours From 22 To 24 Hours

뉴스 본문을 불러오고 있어요.

Amgen Says FDA Approved Prescribing Information Update Cutting IMDELLTRA Monitoring Time For First Two Doses To 6 To 8 Hours From 22 To 24 Hours | 웨이프 WAPE

Amgen Says FDA Approved Prescribing Information Update Cutting IMDELLTRA Monitoring Time For First Two Doses To 6 To 8 Hours From 22 To 24 Hours

기사 요약

관련 종목

댓글 —